front 1 Hospital and Health Care Facilities A health care facility is an organization that provides a physical environment for patients to obtain health care services such as a hospital, LTCF, a mental health facility, drug abuse treatment center, a penal institution or hospice. T/F All hospitals and health care facility pharmacies providing services involving the practice of pharmacy must register with the North Carolina Board of Pharmacy to receive a pharmacy permit. | back 1 TRUE NOTE: Healthcare facilities that ONLY administer drugs are exempt from registering with the North Carolina Board of Pharmacy similar to an outpatient surgical center. |
front 2 What are THREE instances when separate pharmacy registrations/permits for dispensing drugs are required for healthcare facilities? | back 2
|
front 3 The dispensing of drugs from physician's offices owned by the health care facility shall require a separate registration if: I. The drugs dispensed at the location are ordinarily and customarily obtained from a source outside of the healthcare facility. II. The Pharmacist manager is controlled and supervised from a source other than the health care facility pharmacy. III. The routine activity at the location is dispensing drugs to outpatients. A. I only B. I and II only C. II and III only D. All | back 3 D. All |
front 4 T/F Any pharmacy that provides compounding or dispensing services to one or more health care facilities for individual patient administration bearing any labeled name other than that under which it is registered shall require a separate registration. | back 4 TRUE |
front 5 If a hospital or healthcare facility is handling controlled substances, who must they be registered with? | back 5 NC Drug Control Unit NOTE: Community or retail pharmacies do not have to register with the NC Drug Control unit. |
front 6 If a hospital or healthcare facility is handling controlled substances, how often must they renew their registration with the NC Drug Control Unit? | back 6 Annually |
front 7 T/F | back 7 TRUE |
front 8 When discrepancies occur with controlled substance counts in a hospital or healthcare facility, Pharmacist Managers must report to which of following? I. NC Board of Pharmacy II. DEA III. FDA A. I only B. I and II only C. II and III only D. I, II and III | back 8 B. I and II only |
front 9 How soon shall discrepancies with controlled substance counts in a hospital or healthcare facility be reported to the Pharmacy Manager? | back 9 Within 24 hours |
front 10 In a hospital or healthcare facility medications are dispensed only upon receipt of a medication order. Medication Orders in a Hospital or Heathcare Facility can be in written, oral, fax or electronic form. NINE Elements of a Medication Order. | back 10
NOTE: There are no restrictions on the form of medication orders. Medication orders are not prescriptions. |
front 11 In a hospital or healthcare facility medications are dispensed only upon receipt of a medication order. Medication Orders in a Hospital or Heathcare Facility can be in written, oral, fax or electronic form. What do Medication Orders in a patient's profile contain? | back 11
|
front 12 T/F In a hospital or healthcare facility medications orders can be given in oral form. Oral medication orders shall be recorded immediately and signed by the physician. | back 12 TRUE |
front 13 In a hospital or healthcare facility which of the following are measures that can be taken to avoid indefinite open-ended medication orders? I. Routine monitoring of patient's drug therapy by pharmacist II. Automatic Stop Order Policy covering those medication orders that do not specify a number of doses or duration of therapy III. Automatic Cancellation of all medication orders after a predetermined time interval. A. I only B. I and II only C. II and III only D. I, II and III | back 13 D. I, II and III |
front 14 How often must healthcare facilities who credential practitioners for prescribing privileges provide the pharmacy with credentialling information for each practitioner? | back 14 Annually OR immediately if privileges are revoked NOTE: This lets the pharmacy know what practitioners are approved by the healthcare facility to write medication orders and see patients at that facility. |
front 15 In a hospital or healthcare facility all drugs dispensed must be labeled and identified to the point of administration. Labeling Requirements for Medications in a Hospital or Healthcare Facility: | back 15 no data |
front 16 In a hospital or healthcare facility all drugs dispensed must be labeled and identified to the point of administration. Additional Labeling Requirements for Parenteral Admixtures: | back 16
|
front 17 In a hospital or healthcare facility all drugs dispensed must be labeled and identified to the point of administration. Additional Labeling Requirements for Compounds: | back 17
|
front 18 Auxiliary Medication Inventories contain drugs and devices only in amounts to meet immediate therapeutic needs of patients. THREE Examples of Auxiliary Medication Inventories. | back 18
NOTE: Pharmacist manager and health care facility staff shall develop a list of drugs and devices. An auxiliary medication inventory shall ONLY contain drugs and devices only in amounts to meet immediate therapeutic needs of patients. |
front 19 The pharmacist manager in consultation with the medical staff must develop a list of drugs and devices that may be stocked in Auxiliary Medication Inventories. These drugs shall be labeled. What are the labeling requirements for drugs contained in Auxiliary Medication Inventories? | back 19
|
front 20 When medications are taken out of the Auxiliary Medication Inventory. What must be recorded after withdrawal? | back 20
|
front 21 Which of the following is designed to meet the immediate therapeutic needs of patients? I. Emergency Kits II. Patient Care Unit Medication Inventories III. Ancillary Drug Cabinets Inventories A. I only B. I and II only C. II and III only D. I, II and III | back 21 D. I, II and III NOTE: Auxiliary Medication Inventories |
front 22 T/F | back 22 TRUE NOTE: The ONLY exception is when being used as an emergency kit. |
front 23 T/F In a healthcare facility setting, controlled substances may be stocked and removed from auxiliary medication inventories. | back 23 TRUE NOTE: Hospital or healthcare facility must make sure there is a record of these controlled substances. |
front 24 Which of the following is/are TRUE regarding auxiliary medication inventories? I. Only drugs in unit dose packaging shall be removed from the auxiliary medication inventory or from the pharmacy and administered to a specific patient in amounts to meet the needs for immediate therapeutic requirements. II. Controlled substances may be stocked and removed from auxiliary medication inventories. III. Drugs in auxiliary medication inventories shall be pre-labeled by the pharmacist with the drug name, strength, lot # and expiration date. A. I only B. I and II only C. II and III only D. All | back 24 D. All |
front 25 Which of the following describes a mechanical system that performs functions relating to the storage, packaging, counting, labeling and dispensing of medications and collects, controls, and maintains all transaction information? | back 25 Automated Dispensing or Drug Supply Device i.e., Pyxis machine NOTE: Can also be used as an auxiliary medication inventory or emergency kit. |
front 26 Medication orders need to be prospectively verified by the pharmacist before the nurse removes the drug from a automated dispensing device (pyxis machine). What are THREE exceptions to this rule? | back 26
|
front 27 T/F Automated Dispensing Devices may only be stocked by a pharmacist. | back 27 FALSE Automated Dispensing Devices can be stocked by non-pharmacist personnel. |
front 28 Automated Dispensing Devices can be stocked by non-pharmacist personnel. Name THREE procedures that can be used for verification of stocking an Automated Dispensing Device. | back 28
|
front 29 THREE Qualifications of Validating Technicians. | back 29
|
front 30 Which of the following activities may a Validating Technician perform? I. Stock of patient care unit medications II. Stocking of ancillary drug cabinet inventories. III. Stocking of automated dispensing or drug supply devices. A. I only B. I and II only C. II and III only D. I, II and III | back 30 D. I, II and III |
front 31 Which of the following activities may a Validating Technician perform? I. Stock of emergency kits II. Validate the filling of floor stock and unit dose distribution systems. III. Prepackaging of prescription drugs within the hospital pharmacy. A. I only B. I and II only C. II and III only D. I, II and III | back 31 D. I, II and III |
front 32 Which of the following activities may a Validating Technician perform? A. Prepackage medications B. Stock Automated Dispensing Systems C. Verify a patient-specific medication order D. A & B E. All of the above | back 32 D. A & B NOTE: Verifying a patient-specific drug order can only be done by a pharmacist. |
front 33 How long shall transaction records (non-controlled and controlled medications) distributed by an Automated Dispensing Devices be kept? | back 33 3 years |
front 34 T/F Medication reuse from an Automated Dispensing Device is permissible. | back 34 TRUE NOTE: As long as the drug's purity, packaging and labeling have been examined, and it has been approved. |
front 35 T/F Automated Dispensing Devices must be used in a facility with a pharmacy permit. | back 35 TRUE NOTE: If NOT, it can ONLY be used as an emergency kit. |
front 36 In Summary Describe an Auxiliary Medication Inventory. | back 36
|
front 37 In Summary Describe an Automated Dispensing Device. | back 37
|
front 38 The emergency department staff is complaining about the long time it takes the pharmacy to deliver certain medications during a code situation. Which of the following ways could the pharmacy improve their turn around time? A. Install an Auxiliary Medication Inventory such as a drug cabinet B. Install an Automated Dispensing Device such as a Pyxis machine C. Both of the above D. Neither of the above | back 38 C. Both of the above NOTE: Auxiliary Medication Inventory is used to meet immediate therapeutic needs, however an Automated Dispensing Device can also be used as an Auxiliary Medication Inventory. |
front 39 Which of the following would be appropriate for a hospital pharmacy to install in order to quickly dispense patients' maintenance medications (i.e Metformin)? A. Auxiliary Medication Inventory such as a drug cabinet B. Automated Dispensing Device such as a Pyxis machine C. Both of the above D. Neither of the above | back 39 B. Automated Dispensing Device such as a Pyxis machine NOTE: This is not for the immediate therapeutic need of a patient; therefore, Auxiliary Medication Inventory would not be appropriate. |
front 40 Repackaging in a Hospital or Healthcare Facility Pharmacy T/F | back 40 FALSE Hospital or healthcare facilities DO NOT NEED TO register as a "Repackager" to repacking medications. |
front 41 Labeling Requirements for Repackaged Medications. | back 41
NOTE: Repackaging should be performed by or under the supervision of a pharmacist. |
front 42 Absence of a Pharmacist at a Hospital or Healthcare Facility In a healthcare facility a pharmacy is not open 24 hours a day, 7 days a week, arrangements need to be made for the provision of drugs and pharmaceutical care. What are the TWO options that the pharmacist-manager has to assure access to drugs in the absence of a pharmacist? | back 42
|
front 43 In absence of a pharmacist in a hospital or health care facility a nurse may be authorized to remove drugs from the pharmacy if... SATA A. Drug needed is not in auxiliary medication inventory' B. "On call" pharmacist is accessible C. Pharmacist maintains a list of authorized persons and documents the initial orientation, continuing education and quality control process. D. Pharmacist maintains a list of restricted medications that may not be removed from the pharmacy. | back 43 A. Drug needed is not in auxiliary medication inventory' B. "On call" pharmacist is accessible C. Pharmacist maintains a list of authorized persons and documents the initial orientation, continuing education and quality control process. D. Pharmacist maintains a list of restricted medications that may not be removed from the pharmacy. |
front 44 Which of the following are requirements for a nurse to remove medications from the pharmacy during the times a hospital pharmacy is not open? SATA A. Nurse must contact "on call" pharmacist for all medications removed B. Nurse must receive adequate training for removing medications from the pharmacy. C. All medications can be removed by a nurse from the pharmacy. D. Medication must be pre-labeled by a pharmacist. | back 44 A. Nurse must contact "on call" pharmacist for all medications removed B. Nurse must receive adequate training for removing medications from the pharmacy. D. Medication must be pre-labeled by a pharmacist. NOTE: Drugs must be pre-labeled by the pharmacist with the drug name, strength, lot # and expiration date. |
front 45 If a nurse removes a medication from a hospital pharmacy which is NOT OPEN 24 hours a day, during the absence of a pharmacist, within how many hours must a pharmacist obtain and verify a medication order? A. 24 hours B. 48 hours C. 72 hours D. 96 hours | back 45 A. 24 hours |
front 46 How long shall a record of medications removed from auxiliary medication inventories or from pharmacy inventory be kept? | back 46 3 years |
front 47 How often shall the pharmacist-manager verify the accuracy of the records of medications removed? | back 47 Quarterly |
front 48 T/F Supportive personnel may work in the pharmacy during the absence of a pharmacist. | back 48 TRUE NOTE: To perform clerical, repackaging and distributive functions. Drugs may leave the pharmacy ONLY if checked by a pharmacist. |
front 49 T/F | back 49 FALSE Controlled substances MAY be stocked and removed from auxiliary medication inventories. Controlled substances CANNOT be removed from the pharmacy in the absence of a pharmacist. |
front 50 In a hospital or healthcare facility pharmacy the responsible pharmacists and pharmacy technicians for medication compounding and dispensing must be recorded and identified. How long must these records be kept? | back 50 30 days |
front 51 In a hospital or healthcare facility a Pharmacist-Manager shall document medication errors resulting from the administration of an incorrect medication or dose. How long shall these records be kept | back 51 3 years |
front 52 In a hospital or healthcare facility a Pharmacist-Manager shall retain all documents, labels, vials, supplies, substances, and internal investigation reports relating to an event where a prescription drug has caused or contributed to death of a patient. How long shall these records be kept? | back 52 3 years NOTE: When a patient dies as a result of a medication error it must be reported to the NC Board of Pharmacy within 14 days |
front 53 In a hospital or healthcare facility a Pharmacist-Manager shall maintain records of ordering, receiving, dispensing, or transfer of controlled substances. How long shall these records be kept? | back 53 3 years |
front 54 T/F | back 54 TRUE |
front 55 How soon must records from a hospital or healthcare facility be available to the NC Board of Pharmacy? | back 55 Within 48 hours |
front 56 T/F All hospital records must be kept for 3 years. | back 56 FALSE Day to day records that identify the responsible pharmacist and pharmacy technician for medication compounding and dispensing must be kept for 30 days. |
front 57 Health Care Facility Emergency Departments are permissible to dispense medications to patients of emergency departments and for patients to take home. Labeling Requirements for Medications Dispensed from ED | back 57
|
front 58 Which of the following are TRUE regarding medications being dispensed from a healthcare facility emergency department? I. A prescription needs to be issued from a practitioner. II. Patient is required to be counseled. III. If a 24-hour outpatient pharmacy is not available a prescription may be dispensed and is limited to not more than a 48-hour supply or the smallest commercially available quantity. A. I only B. I and II only C. II and III only D. I, II and III | back 58 B. I and II only NOTE: If a 24-hour outpatient pharmacy is not available a prescription may be dispensed and is limited to not more than a 24-hour supply or the smallest commercially available quantity. |
front 59 An emergency department of health care facilities having 24-hour outpatient pharmacy service shall consist of drugs that meet the immediate needs of emergency department patients. Quantities in each container shall me limited to not more than: A. 24-hour supply B. 48-hour supply C. 72-hour supply D. a weekly supply | back 59 A. 24-hour supply |
front 60 How long should a Perpetual Record of all dispensed drugs be maintained with pharmacy records? | back 60 3 years |
front 61 In a Hospital and Healthcare Facility Pharmacy the Perpetual Record should contain. | back 61
|
front 62 How often shall a Pharmacist-Manager of a hospital or healthcare facility pharmacy verify the accuracy of a Perpetual Record? | back 62 Monthly |
front 63 Medication orders in health care facilities, without a quantity indicated on the order, should be limited to which of the following day supply? A. 7 days B. 15 days C. 30 days D. 60 days | back 63 C. 30 days |
front 64 Long Term Care Facilities T/F An automated dispensing device can be installed in a LTCF by a retail pharmacy registered with the DEA. LTCFs are allowed to have controlled substances in an automated dispensing device. | back 64 TRUE NOTE: ONLY if registered with the DEA. If not registered with the DEA LTCFs may not order or maintain stocks of controlled substances. |
front 65 T/F The retail pharmacy that installs the Automated Dispensing Device must maintain a separate DEA registration at the LTCF location. | back 65 TRUE NOTE: Retail Pharmacy may keep records of the Automated Dispensing Device at their pharmacy. |
front 66 T/F | back 66 TRUE NOTE: Can apply for a Limited-Service Permit. |
front 67 T/F A pharmacy can place an emergency kit with controlled substances in a non-DEA registered LTCF. | back 67 TRUE NOTE: The pharmacy is responsible for the emergency kit and must be registered with the DEA. Therefore, it is considered an extension of the pharmacy and is covered under the pharmacy's DEA registration. A separate DEA registration is not needed. unlike when a pharmacy placed an Automated Dispensing Device in a LTCF that contains controlled substances. |
front 68 How many controlled substances can be contained in an Emergency Kit within a LTCF? | back 68 7 Controlled Drug Entities (C-II through C-V)
|
front 69 What must be established for a LTCF nurse or employee to be an agent of the patient's prescriber? | back 69 Written agreement |
front 70 LTCF Agents of a Prescriber (LTCF nurse or employee) may perform which of the following tasks? I. Call in an emergency oral C-II prescription to the pharmacy II. Transmit a fax prescription for all controlled (including C-II) and non-controlled substances from the prescriber. III. Prepare a written prescription for the signature of the practitioner. A. I only B. I and II only C. II and III only D. I, II and III | back 70 C. II and III only NOTE: Agents of a prescriber at a LTCF can ONLY call in a prescription for non-controlled substances and CIII, CIV and CV to the pharmacy. |
front 71 Nuclear Pharmacy (Not Completed) How many hours of TRAINING must a NUCLEAR Pharmacist receive? | back 71
|
front 72 Label Affixed to the Immediate INNER Container of Radiopharmaceutical, | back 72
|
front 73 Label Affixed to the Immediate OUTER Container of Radiopharmaceutical, | back 73
|
front 74 What protects individually identifiable health information held or transmitted by a covered entity or its business associate? | back 74 HIPAA |
front 75 HIPAA is also known as | back 75 Protected Health Information (PHI) |
front 76 HIPAA... I. Relates to the individuals past, present or future physical or mental health or condition II. Identifies the individual name, address, phone number or vehicle information. III. Includes electronic, paper or oral form A. I only B. I and II only C. II and III only D. I, II and III | back 76 D. I, II and III |
front 77 A covered entity must comply with HIPAA and includes health care plans, health care providers such as prescribers, pharmacies and pharmacists, and personnel that conduct transactions electronically. What are TWO exemptions for when a covered entity may disclose Protected Health Information (PHI)? | back 77
NOTE: Personal representative is a person legally authorized to make health care decisions on individual's behalf such as a parent of a minor or a person who has power of attorney. |
front 78 What are THREE exemptions for when a pharmacy can disclose Protected Health Information (PHI)? | back 78
NOTE: "TPO" |
front 79 HIPAA does not require that every risk of an incidental use or disclosure of PHI be eliminated. What must pharmacies implement to prevent the disclosure of information? | back 79 Reasonable Safeguards NOTE: Designated areas for counseling, stand behind this line signs, using indoor voices. |
front 80 When protecting patient's health information, the use of only the minimum amount of information is necessary to accomplish the intended purpose of the use, disclosure or request. Pharmacies should use the "Minimum Necessary" when possible. What are FOUR exceptions to the "Minimum Necessary" requirement? | back 80
|
front 81 Each covered entity (including a pharmacy) must provide a notice of its privacy practices. Which of the following are TRUE regarding Privacy Practice Notice? I. Notice must contain several elements, concerning how the covered entity will use the patient's PHI, safeguards and grievance process. II. Notice must be posted in a clear and prominent place. III. Notice must be delivered to patients not later than the second service encounter. A. I only B. I and II only C. II and III only D. I, II and III only | back 81 B. I and II only NOTE: Notice must be delivered to patients not later than the FIRST service encounter. |
front 82 T/F A covered entity must supply Privacy Practice Notice to anyone on request and make electronically available on web site. | back 82 TRUE |
front 83 T/F Pharmacies must make a good faith effort to obtain a written, electronic or mail acknowledgement by all patients that they received the Privacy Practice Notice. | back 83 TRUE |
front 84 T/F If a patient refuses to sign the acknowledgement of Privacy Practice Notice Receipt, treatment can be refused. | back 84 FALSE If a patient refuses to sign the acknowledgement of Privacy Practice Notice Receipt, treatment CANNOT be refused. NOTE: Only can be signed by the patient or the patient's personnel representative (Parent of minor or Power of Attorney) Only required ONCE for each patient even if you update your Privacy Practice Notice. |
front 85 Which of the following is TRUE regarding acknowledgement of Privacy Practice Notice when received by the patient? I. Treatment can be refused if the patient refuses to sign the Privacy Practice Notice. II. The reason for failing to obtain the patient's written acknowledgement must be documented. III. Written acknowledgement is only required once for each patient. A. I only B. I and II only C. II and III only D. I, II, and III | back 85 C. II and III only If a patient refuses to sign the acknowledgement of Privacy Practice Notice Receipt, treatment CANNOT be refused. |
front 86 The acknowledgement of Privacy Practice Notice can only be signed by the patient or the patient's personnel representative (parent of minor or Power of Attorney). If a prescription is filled for a patient and their spouse picks up the prescription and the spouse does not have Power of Attorney. How will the Privacy Practice Notice be signed? | back 86 The Privacy Practice Notice may be sent to the patient by mail to be acknowledged and signed by the patient. |
front 87 A breach of PHI is defined as an impermissible use or disclosure under the privacy rule that compromises the security of the protected health information. TWO Exceptions of a Protected Health Information (PHI) Breach. | back 87
|
front 88 The pharmacy must determine if a breach occurred and document if the breach met an exclusion. How long must documentation of a potential breach be retained? | back 88 6 years |
front 89 On a federal level, following the discovery of a breach, who must be notified? I. Individuals Affected by the Breach II. The Secretary of DHHS III. The Secretary of DEA A. I only B. I and II only C. II and III only D. I, II, and III | back 89 B. I and II only |
front 90 On a federal level, how soon must covered entities notify affected individuals following the discovery of a breach? | back 90 Without unreasonable delay and no later than 60 days after discovery by mail or electronically |
front 91 On a federal level, how soon must covered entities notify the Secretary of DHHS following the discovery of a breach? | back 91 No later than 60 days after the end of the calendar year in which the breach was discovered |
front 92 On a federal level, if MORE THAN 500 individuals are affected by a breach, who must the pharmacy notify? I. The affected individuals II. The Secretary of DHHS III. The media A. I only B. I and II only C. II and III only D. I, II, and III | back 92 D. I, II, and III NOTE: |
front 93 On a federal level, if MORE THAN 500 individuals are affected by a breach, how soon must the pharmacy notify individuals affected, the secretary of DHHS, and the media? | back 93 Without unreasonable delay and no later than 60 days after discovery of breach |
front 94 In North Carolina a breach of personal health information requires notification without unreasonable delay to which of the following: I. Secretary of DHHS II. Individuals Affected by the Breach III. North Carolina Attorney General's Consumer Protection Division A. I only B. I and II only C. II and III only D. I, II, and III | back 94 C. II and III only |
front 95 In North Carolina, if a breach includes more than _________ individuals, all reporting agencies must be notified. | back 95 In North Carolina, if a breach includes more than 1,000 individuals, all reporting agencies must be notified. |
front 96 Marketing is communication by telephone mail and/or email about a product or service that encourages the recipient to purchase or use the product or service. What are FOUR exceptions to the definition of marketing? | back 96
|
front 97 Which of the following is considered marketing? I. Communication by telephone II. Communication by mail or email III. Communication face to face A. I only B. I and II only C. II and III only D. I, II and III | back 97 B. I and II only |
front 98 Which of the following is considered marketing? I. A covered entity selling personal health information (PHI) to another business for that business' own purposes. II. Describing health related products or services offered by the covered entity. III. Handing patients printed drug information. A. I only B. I and II only C. II and III only D. I, II and III | back 98 A. I only |
front 99 A covered entity may sell personal health information to another business for that business' own purposes however, a covered entity must obtain patient authorization for any use or disclosure of personal health information for marketing purposes. What must this authorization include? | back 99
|
front 100 T/F Covered entities must document that each employee has completed HIPAA training. | back 100 TRUE |
front 101 T/F Covered entities must develop policies and procedures and identify a privacy officer to oversee the entity's compliance with HIPAA. | back 101 TRUE |
front 102 Miscellaneous Federal Pharmacy Laws Adulterated OR Misbranded Contains in whole/part any filthy, putrid or decomposed substance | back 102 Adulterated |
front 103 Adulterated OR Misbranded Generic or established name is not on the label. | back 103 Misbranded |
front 104 Adulterated OR Misbranded Has been prepared, packaged or held under unsanitary conditions | back 104 Adulterated |
front 105 Adulterated OR Misbranded The labeling is false or misleading in any manner. | back 105 Misbranded |
front 106 Adulterated OR Misbranded Has been manufactured under conditions that do not meet GMP standards. | back 106 Adulterated |
front 107 Adulterated OR Misbranded Quantity of container contents are not present. | back 107 Misbranded NOTE: Word, statement or other information not prominently placed on label as required by law. |
front 108 Adulterated OR Misbranded Medications stored in room with extreme temperatures. | back 108 Adulterated |
front 109 Adulterated OR Misbranded Manufacture, packer or distributor name and place of business not on label. | back 109 Misbranded |
front 110 Adulterated OR Misbranded Manufacture is not registered with the FDA | back 110 Misbranded |
front 111 Adulterated OR Misbranded Dispensing a prescription without a prescription or refills. | back 111 Misbranded |
front 112 Adulterated OR Misbranded Strength, quality or purity differs from compendia standards (USP). | back 112 Adulterated |
front 113 Adulterated OR Misbranded Dispensing the incorrect strength of a prescription drug. | back 113 Misbranded |
front 114 Adulterated OR Misbranded Not following regulations of the Poision Prevention Packaging Act. | back 114 Misbranded |
front 115 Adulterated OR Misbranded Failure to manufacture OTC products in tamper evident packaging. | back 115 Misbranded or Adulterated |
front 116 A new OTC medication claims that it will reverse coronary atherosclerosis if taken. Upon further investigation of the FDA, the manufacturer does not have clinical data to prove this statement. Which of the following violations have occurred? A. Adulteration B. Misbranding | back 116 B. Misbranding |
front 117 A pharmacy dispenses nitroglycerin to a patient in a plastic vial. Nitroglycerin adheres to plastic causing a loss of potency. Which of the following violations have occurred? A. Adulteration B. Misbranding | back 117 A. Adulteration |
front 118 If a pharmacy dispenses Atorvastatin to a patient and the patient does not have any valid refills remaining, which of the following violations occurred? A. Adulteration B. Misbranding | back 118 B. Misbranding |
front 119 If a marketed drug product exhibits problems, the manufacture is encouraged to issue a drug recall notice. Class 1 Drug Recall (Most Severe) | back 119
|
front 120 If a marketed drug product exhibits problems, the manufacture is encouraged to issue a drug recall notice. Class 2 Drug Recall | back 120
|
front 121 If a marketed drug product exhibits problems, the manufacture is encouraged to issue a drug recall notice. Class 3 Drug Recall (Least Severe) | back 121
|
front 122 What insulin(s) are over the counter and do not require a prescription? | back 122
NOTE: Prescription ONLY insulins include Regular U-500, Humalog, Novolog, Lantus and Levemir |
front 123 Which Regular Insulin is prescription ONLY? | back 123 Regular Insulin U-500 |
front 124 All healthcare facilities are prohibited from discharging hazardous waste pharmaceuticals to a sewer system such as down a sink or flushing down a toilet. Hazardous waste includes any drug that is identified as ignitability, corrosivity, reactivity or toxicity. Which of the following classes of drugs are prohibited from being discharged into a sewer system? I. Prescription Drugs II. Compounded Drugs III. OTC and Dietary Supplements A. I only B. I and II only C. II and III only D. I, II and III | back 124 D. I, II and III |
front 125 What is a unit of drug not intended for sale and intended to promote the sale of the drug product? | back 125 Drug Sample |
front 126 T/F Pharmacies may receive drug samples, but are prohibited from dispensing drug samples. | back 126 FALSE Pharmacies are prohibited from receiving and dispensing drug samples. |
front 127 T/F Prescribers do not need a pharmacy permit if they are only dispensing drug samples. Prescribers must follow all packaging, labeling and record keeping requirement laws for prescription drugs when dispensing drug samples. | back 127 TRUE |
front 128 T/F | back 128 FALSE Manufactures can distribute a controlled substance drug sample to a PRESCRIBER only after the PRESCRIBER makes a written request. |
front 129 Manufactures can distribute a controlled substance drug sample to a PRESCRIBER only after the PRESCRIBER makes a written request. What is included in the written request for a controlled substance drug sample? | back 129
|
front 130 Manufactures can distribute a controlled substance drug sample to a PRESCRIBER only after the PRESCRIBER makes a written request. How long must the manufacture keep the written request? | back 130 3 years |
front 131 T/F | back 131 TRUE |
front 132 FDA requires a pharmacy to dispense a manufacturer-provided patient package insert (PPI) to the patient. What medications require a patient package insert? | back 132
NOTE: Regulated by the FDA. |
front 133 In a community pharmacy when is the Patient Package Insert (PPI) given to the patient? In a hospital/institutional pharmacy when is a Patient Package Insert (PPI) given to the patient? | back 133 Community: Given with each package dispensed Institutional Hospital: Before administration of first oral contraception and 30 days thereafter |
front 134 T/F Drug leaflets are regulated by the FDA and are required to be provided to all patients when dispensing medications. | back 134 FALSE Drug leaflets are not regulated by the FDA and it is left up to individual pharmacies to provide for all medications dispensed. |
front 135 What is given and applies to certain drugs and biological products that the FDA determines to pose a serious and significant public health concern? | back 135 MedGuides |
front 136 Give FOUR examples of medications that require a MedGuide. | back 136
|
front 137 Manufactures provide the MedGuides to the pharmacy. MedGuides are required if: I. Could help prevent serious adverse effects II. There is a serious risk that a patient should be aware of. III. Patient adherence to directions is crucial. A. I only B. I and II only C. II and III only D. I, II and III | back 137 D. I, II and III |
front 138 What is required and ensures that the benefits of certain prescription drugs outweigh their risk? | back 138 Risk Evaluation and Mitigation Strategy (REMS) NOTE: Healthcare professionals and distributors may need to follow specific safety procedures prior to prescribing, shipping or dispensing the drug. |
front 139 FOUR Elements of the REMS Program | back 139
|
front 140 THREE Examples of REMS Medications. | back 140
|
front 141 Prescriptions must be designated to prevent unauthorized copying, erasure or modification and use of counterfeit prescriptions. T/F Written outpatient Medicaid prescriptions must be written on tamper-resistant prescription pads. | back 141 TRUE |
front 142 What are 340B Drugs? | back 142 Medications that are provided to a contract pharmacy at a reduced cost and are dispensed to underserved and uninsured populations. |
front 143 T/F Pharmacies may only dispense 340B drugs to patients in the 340B program. | back 143 TRUE |
front 144 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Non-Sterile Drug Product with an "In-Use" Time | back 144 "In-Use" Time or Expiration Date (whichever is shorter) |
front 145 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Non-Sterile Drug Product NONAQUEOUS formulation (tablet or capsule): | back 145 6 months OR Expiration Date (whichever is shorter) |
front 146 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Non-Sterile Drug Product Water Containing Oral Formulation (Solution or Suspensions): | back 146 14 days OR Expiration Date (whichever is shorter) |
front 147 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Non-Sterile Drug Product Water Containing Topical/Dermal and Mucosal Liquid and Semisolid Formulations. | back 147 30 days OR Expiration Date (whichever is shorter) |
front 148 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Sterile Drug Products with an "In-Use" Time | back 148 "In-Use" Time OR Expiration Date (whichever is shorter) |
front 149 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Sterile Drug Products without In-Use Time | back 149 According to USP 797 OR Expiration Date (whichever is shorter) |
front 150 EIGHT Labeling Factors of Over-the-Counter Drug Products. | back 150
|
front 151 National Drug Code (NDC) Number How many digits are contained in an NDC Number? | back 151 11 Digits (3 Segements) |
front 152 There are 11 digits and 3 segments in an NDC number. What does each segment represent? | back 152
|
front 153 What is the Federal Anti-Tampering Act? | back 153 This act requires manufacturers to package OTC drugs in tamper-evident packaging. |
front 154 Medical Devices: Which class of medical devices requires "specific controls" to be met and includes blood pressure cuffs, syringes and percutaneous catheters? | back 154 Class II |
front 155 Medical Devices: Which class of medical devices requires manufactures to provide "general controls" during the production of the device and includes stethoscopes, bandages and crutches. | back 155 Class I |
front 156 Medical Devices: Which class of medical devices require premarket approval because the device is life-sustaining, important in preventing impairment of human health and includes pacemakers, replacement heart valves, coronary stents? | back 156 Class III |
front 157 TWO USPS Mailing Requirements for Controlled Substances. | back 157
|
front 158 USP 800 Describes practice and quality standards for the receipt, storage, compounding, dispensing, administration and disposal of sterile and nonsterile Hazardous Drugs (HDs). Hazardous drugs are identified by: | back 158 National Institute for Occupational Safety and Health (NIOSH) |
front 159 How often must entities review their list of hazardous drugs? | back 159 Every 12 months or when a new agent or dosage form is introduced |